Conference Coverage Long-Term Treatment With Interferon Beta-1a or Glatiramer Acetate May Be Cost-Effective Read More
Conference Coverage 11-Year Data From BENEFIT Trial Support Early Treatment of Interferon Beta-1b for CIS Read More
Conference Coverage Computerized Cognitive Test May Be a Valid Assessment for Patients With MS Read More
Conference Coverage Age and DMT Exposure May Predict Conversion From Clinically Isolated Syndrome to MS Read More
